Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-04-23

Clinical Trial Update: Efficacy and Safety of SH T00660AA in Treatment of Endometriosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating SH T00660AA for endometriosis has completed, collecting efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SH T00660AA

Snippet

Sponsor: Bayer | Conditions: Endometriosis | Phase 3 | Status: COMPLETED